These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8648818)

  • 1. Transperineal photodynamic ablation of the canine prostate.
    Selman SH; Keck RW; Hampton JA
    J Urol; 1996 Jul; 156(1):258-60. PubMed ID: 8648818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.
    Selman SH; Albrecht D; Keck RW; Brennan P; Kondo S
    J Urol; 2001 May; 165(5):1795-801. PubMed ID: 11342978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy.
    Jankun J; Lilge L; Douplik A; Keck RW; Pestka M; Szkudlarek M; Stevens PJ; Lee RJ; Selman SH
    J Urol; 2004 Aug; 172(2):739-43. PubMed ID: 15247773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
    Aniola J; Selman SH; Lilge L; Keck R; Jankun J
    Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial photodynamic therapy of the canine prostate using intra-arterial administration of photosensitizer and computerized pulsed light delivery.
    Xiao Z; Dickey D; Owen RJ; Tulip J; Moore R
    J Urol; 2007 Jul; 178(1):308-13. PubMed ID: 17499802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study.
    Selman SH; Keck RW
    J Urol; 1994 Dec; 152(6 Pt 1):2129-32. PubMed ID: 7966701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathoracic organ injury associated with photodynamic therapy.
    Pelton JJ; Kowalyshyn MJ; Keller SM
    J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1218-23. PubMed ID: 1534592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
    Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer.
    Mang TS; Allison R; Hewson G; Snider W; Moskowitz R
    Cancer J Sci Am; 1998; 4(6):378-84. PubMed ID: 9853137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy.
    Jankun J; Keck RW; Skrzypczak-Jankun E; Lilge L; Selman SH
    BJU Int; 2005 Jun; 95(9):1237-44. PubMed ID: 15892808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy in the canine prostate using motexafin lutetium.
    Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
    Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.
    Moshfeghi DM; Peyman GA; Moshfeghi AA; Khoobehi B; Primbs GB; Crean DH
    Ophthalmic Surg Lasers; 1998 Aug; 29(8):663-8. PubMed ID: 9715492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
    Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
    Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold dose of three photosensitizers in dogs with spontaneous tumors.
    Gloi AM; Beck E
    Vet Ther; 2003; 4(3):269-78. PubMed ID: 15136988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).
    Peyman GA; Moshfeghi DM; Moshfeghi A; Khoobehi B; Doiron DR; Primbs GB; Crean DH
    Ophthalmic Surg Lasers; 1997 May; 28(5):409-17. PubMed ID: 9150524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for corneal neovascularization.
    Primbs GB; Casey R; Wamser K; Snyder WJ; Crean DH
    Ophthalmic Surg Lasers; 1998 Oct; 29(10):832-8. PubMed ID: 9793949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery.
    Hill RA; Crean DH; Doiron DR; McDonald TJ; Liaw LH; Ghosheh F; Hamilton A; Berns MW
    Ophthalmic Surg Lasers; 1997 Jul; 28(7):574-81. PubMed ID: 9243661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of three photosensitizers in dogs with spontaneous tumors.
    Gloi AM; Beck E
    Vet Ther; 2003; 4(2):155-65. PubMed ID: 14506591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatments for localized prostate cancer.
    Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
    Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of rat endometrium sensitized with tin ethyl etiopurpurin.
    Rocklin GB; Kelly HG; Anderson SC; Edwards LE; Gimpelson RJ; Perez RE
    J Am Assoc Gynecol Laparosc; 1996 Aug; 3(4):561-70. PubMed ID: 9050689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.